Assess whether RWE can replace or only supplement an RCT (bc88da)

Situation

The Pharmacovigilance desk packet is complete-response-letter deficiency list after a DSMB note on an imbalance that is not yet a signal. Clinical-development physician in a 505(b)(2) program relying on literature plus a bridging study must name RWE can replace or Only supplement an RCT for this Pharma & Life Sciences file. Clinical-development physician in a 505(b)(2) program relying on literature plus a bridging study has to name RWE can replace or Only supplement an RCT for this Pharma & Life Sciences Pharmacovigilance file.

Decision

Clinical-development physician in a 505(b)(2) program relying on literature plus a bridging study must choose RWE can replace / Only supplement an RCT using complete-response-letter deficiency list after a DSMB note on an imbalance that is not yet a signal.

Hypotheses to test

• The population in complete-response-letter deficiency list is the one a DSMB note on an imbalance that is not yet a signal named, so RWE can replace follows for this Pharmacovigilance file.
• The population in complete-response-letter deficiency list is adjacent only to a DSMB note on an imbalance that is not yet a signal; Only supplement an RCT is the honest Pharma & Life Sciences call.
• A 505(b)(2) program relying on literature plus a bridging study already contained a DSMB note on an imbalance that is not yet a signal before complete-response-letter deficiency list arrived; no new Pharmacovigilance path.
• Provenance on complete-response-letter deficiency list after a DSMB note on an imbalance that is not yet a signal is broken; do not pick RWE can replace or Only supplement an RCT yet.

Analysis required

• Trace CMC, labeling, or pharmacovigilance facts in complete-response-letter deficiency list after a DSMB note on an imbalance that is not yet a signal.
• Separate an isolated adverse event from a systemic quality issue.
• Test a protocol deviation versus a safety signal versus a filing gap on RWE can replace or.
• For this Pharma & Life Sciences Pharmacovigilance file, read complete-response-letter deficiency list against a DSMB note on an imbalance that is not yet a signal and write the one fact that would move RWE can replace or for clinical-development physician.

Recommendation